首页> 外文会议>International symposium on controlled release of bioactive materials;Consumer and diversified products conference >Application of universal hydrophilic matrix (UHM) for transdermal drug delivery systems (TDDS) containing nonsteroidal antiinflamatory drug (NSAID) diclofenac or its salts.
【24h】

Application of universal hydrophilic matrix (UHM) for transdermal drug delivery systems (TDDS) containing nonsteroidal antiinflamatory drug (NSAID) diclofenac or its salts.

机译:《通用》亲水性基质(UHM)在含有非甾体抗炎药(NSAID)双氯芬酸或其盐的透皮给药系统(TDDS)中的应用。

获取原文

摘要

UHM was developed by some of us (1). It has been used in the design of about ten TDDS. Some of them is now registered in Russia (2) as drugs. UHM may be used for the preparation of TDDS involving drugs of very different chemical structure. Many NSAIDs are acids or their salts. In the previous communication (3) we described Indomethacin - containing TDDS, and now we report the design of TDDSs involving most popular NSAID -Diclofenac in acidic or salt form. In ointments the drug may used to short-term treatment, but it is not optimal for long-term treatment or chronic diseases such as artritis.
机译:UHM是我们中的一些人开发的(1)。它已用于约十个TDDS的设计中。其中一些现已在俄罗斯注册为毒品(2)。 UHM可用于制备涉及化学结构非常不同的药物的TDDS。许多NSAID是酸或其盐。在先前的交流中(3),我们描述了含有吲哚美辛的TDDS,现在我们报告涉及酸性或盐形式最流行的NSAID-双氯芬酸的TDDS的设计。在药膏中,该药物可用于短期治疗,但对于长期治疗或慢性疾病(例如关节炎)并不是最佳选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号